Renyuan Biotechnology
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Renyuan Biotechnology - overview
Established
2023
Location
Shenzhen, Guangdong, China
Primary Industry
Biotechnology
About
Established in 2023 and based in Shenzhen, China, Renyuan Biotechnology is a biopharmaceutical company that develops drugs in the field of cardiovascular diseases. The company has established cooperative relationships with the American Academy of Sciences, the Chinese Academy of Sciences University and other research institutes to jointly carry out technology research and development, and transformation of achievements. Dr. Lei Zhang, the founder of the company, was the co-founder and chief scientist of Huayuan Regenerative Medicine and has received the International Society of Transplantation Scientific Award.
In August 2024, it closed a round of seed funding. The company has developed EPC (Vascular Repair Stem Cells), a class of stem cells that circulate, proliferate and differentiate into vascular endothelial cells. Based on this, the company has created an R&D pipeline called VCP series products, which can be used to treat peripheral vascular ischemia, cardiomyopathy, stroke and other diseases. Also under development is the MV3D-01 3D vascular chip, which can provide a vascular platform for artificial organ manufacturing.
The company generates revenue by developing drugs for the treatment of cardiovascular diseases. The company will use the seed funding raised in August 2024 to advance the progress of filing INDs for the VCP-01/02/03 series of products.
Current Investors
Puhe Capital
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.renyuanbiotech.com
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.